OMNI BIOTIC
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

OMNI BIOTIC Trademark

Serial Number: 79307556 • Registration: 6776789

OMNI BIOTIC is a trademark filed by INSTITUT ALLERGOSAN Holding GmbH on January 27, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

INSTITUT ALLERGOSAN Holding GmbH (6 trademarks)

Gmeinstraße 13

Entity Type: 98

Trademark Details

Filing Date

January 27, 2021

Registration Date

July 5, 2022

Published for Opposition

April 19, 2022

Goods & Services

Cosmetics for use on the skin, namely facial lotions, hand lotions, body lotions, skin lotions, body creams, skin creams, eye creams, face creams

Licensing of industrial property rights and copyright

Food supplements, in particular antioxidants, adapted for medical use; dietetic preparations and food supplements for medical use; dietetic preparations for the preparation of beverages for medical use; dietetic preparations for specific medical purposes for balanced diets, food for babies in particular milk powder for babies, food supplements and dietetic nutritional supplements for sports and enhancing performance for medical purposes; mineral food supplements, starch for dietetic or pharmaceutical purposes; food supplements, mainly consisting of vitamins, amino acids, minerals and trace elements for medical purposes; herbal teas for medicinal purposes; pharmaceutical, veterinary and dietetic preparations, as well as preparations for health care, infant formula, cultures of microorganisms for medical or veterinary use; vitamin preparations; medical preparations for weight loosing purposes; appetite suppressants for medical purposes; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; biological preparations for medical purposes, namely probiotic preparations; dietetic substances adapted for medical use; dietetic foods adapted for medical use; enzyme preparations for medical purposes; bouillons and nutritive substances for bacteriological cultures; digestives for pharmaceutical purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 28, 2025 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 7, 2025 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 14, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Oct 13, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 13, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 5, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 5, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 5, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 19, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 11, 2022 XAEC
ASSIGNED TO LIE
Mar 11, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2022 TROA
REFUSAL PROCESSED BY IB
Sep 19, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 1, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 1, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 21, 2021 RFCR
NON-FINAL ACTION WRITTEN
Aug 20, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 16, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 30, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2021 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 25, 2021 SDRC